Validation experiments were confined to hepatocellular carcinoma; whether the same molecular circuits operate in other DCAF7‐high tumours remains to be tested in lineage‐appropriate cell lines, organoids and animal models. The gene discussed is DCAF7; the disease is neoplasm.